Do variable age-related secondary factors affect ventricular geometry in hypertrophic cardiomyopathy?

Advances in Therapy

Volumn 19, Issue 6, 2002, Pages 253-257

  Yalçin, Fatih ^a   Muderrisoglu, Haldun ^a   Korkmaz, Mehmet Emin ^a   Ozin, Bulent ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Age; Echocardiography; Hypertrophic cardiomyopathy; Phenotype

Indexed keywords

ADULT; AGE; AGED; CHILD; ECHOCARDIOGRAPHY; GEOMETRY; HEART VENTRICLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MORPHOLOGY; PHENOTYPE; PROGNOSIS; REVIEW;

EID: 0036881204     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02853170     Document Type: Review

References (40)

1. Goodwin JF. The frontiers of cardiomyopathy. Br Heart J. 1982;48:1-18.
2. Maron BJ, Spirito P, Wesley Y, et al. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 1986;315:610-614.
3. Lompre AM, Nadal-Ginard B, Mahvadi V. Expression of the cardiac ventricular α- and β-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem. 1984;259:6437-6446.
4. Ojamaa K, Samarel AM, Kupfer JM, et al. Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol. 1992;263:E534-E540.
5. Semsarian C, French J, Trent RJ, et al. The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy. Aust N Z J Med. 1997;27:51-58.
6. Vitale DF, Bonow RO, Calabro R, et al. Myocardial ultrasonic tissue characterization in pediatric and adult patients with hypertrophic cardiomyopathy. Circulation. 1996;94:2826-2830.
7. Okada H. An investigation of the collagen in cardiomyopathic hamsters. Hokkaido J Med Sci. 1993;68:894-905.
8. Hamby RI, Antablian A. Hypertrophic subaortic stenosis is not rare in the eighth decade. Geriatrics. 1976;31:71-74.
9. Berger M, Rethy C, Goldberg E. Unsuspected hypertrophic subaortic stenosis in the elderly diagnosed by echocardiography. J Am Geriatr Soc. 1979;27:178-182.
10. Lever HM, Karam RF, Currie PJ, et al. Hypertrophic cardiomyopathy in the elderly: distinction from the young based on cardiac shape. Circulation. 1989;79:580-589.
11. Cohen S, Benichou M, Larbi MB, et al. Myocardiopathie hypertrophique: evolution et pronostic. Soixante observations. Presse Med. 1986;15:423-427.
12. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1989;13:820-823.
13. Klues GK, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26:1699-1708.
14. Krasnow N, Stein RA. Hypertrophic cardiomyopathy in the aged. Am Heart J. 1978;96:326-336.
15. Whiting RB, Powell WJ Jr, Dinsmore RE, et al. Idiopathic hypertrophic subaortic stenosis in elderly. N Engl J Med. 1971;285:196-200.
16. Wadehra D, Ganar RM, Scanlon PJ. Prognosis of hypertrophic cardiomyopathy with asymmetric septal hypertrophy. Postgrad Med J. 1985;61:1107-1109.
17. Savage DD, Castelli WP, Abott RD, et al. Hypertrophic cardiomyopathy and its markers in the general population. The great masquerade revisited: the Framingham study. J Cardiovasc Ultrasonogr. 1983;2:41-47.
18. Brock R. Functional obstruction of the left ventricle (acquired aortic subvalvular stenosis). Guys Hosp Rep. 1957;106:221-238.
19. Yalçin F, Tsujino H, Greenberg N, et al. Real-time three-dimensional echocardiographic evaluation of mitral annular characteristics in myocardial hypertrophy. Eur Heart J. 1999;291:P1599.
20. Yalçin F, Shiota T, Odabashian J, et al. Comparison by real-time three-dimensional echocardiography of left ventricular geometry in hypertrophic cardiomyopathy versus secondary left ventricular hypertrophy. Am J Cardiol. 2000;85:1035-1038.
21. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1987;9:1013-1017.
22. Spirito P, Chiarella F, Carratino L, et al. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989;320:749-755.
23. Hina K, Kusachi S, Iwasaki K, et al. Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value. Clin Cardiol. 1993;16:403-407.
24. Vikstrom KL, Factor SM, Leinwand LA. A murine model for hypertrophic cardiomyopathy. Z Kardiol. 1995;84:49-54.
25. Spirito P, Maron BJ. Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a two-dimensional echocardiographic assessment. Circulation. 1983;67:1100-1118.
26. Qin JX, Shiota T, Lever HM, et al. Left ventricular outflow tract area measured by real-time 3D echocardiography in hypertrophic obstructive cardiomyopathy. J Am Soc Echocardiogr. 1999;12:202M.
27. Ciro E, Maron BJ, Bonow RO, et al. Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy. Am J Cardiol. 1984;53:1103-1109.
28. Horimoto M, Yokota K, Inoue H, et al. Development of obstructive hypertrophic cardiomyopathy from nonobstructive hypertrophic cardiomyopathy. Am J Cardiol. 1998;82:403-405.
29. Krasnow N. Subaortic septal bulge simulates hypertrophic cardiomyopathy by angulation of the septum with age, independent of focal hypertrophy. An echocardiographic study. J Am Soc Echocardiogr. 1997;10:545-555.
30. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058-1064.
31. Solomon SD, Jarcho JA, McKenna WJ, et al. Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest. 1990;86:993-999.
32. Ojamaa K, Samarel AM, Kupfer JM, et al. Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol. 1992;263:E534-E540.
33. Fei L, Slade AK, Prasad K, et al. Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy? J Am Coll Cardiol. 1995;26:472-480.
34. Shimizu M, Sugihara N, Kita Y, et al. Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy. Br Heart J. 1992;67:155-160.
35. Schafers M, Dutka D, Rhodes CG, et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res. 1998;82:57-62.
36. Limbruno U, Strata G, Zucchi R, et al. Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy. Eur Heart J. 1998;19:146-153.
37. Dimitrow PP, Czamecka D, Jaszcz KK, et al. Sex differences in age at onset of symptoms in patients with hypertrophic cardiomyopathy. J Cardiovasc Risk. 1997;4:33-35.
38. Lompre AM, Nadal-Ginard B, Mahdavi V. Expression of the cardiac ventricular α-and β-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem. 1984;259:6437-6446.
39. Rohde LE, Zhi G, Aranki SF, et al. Gender-associated differences in left ventricular geometry in patients with aortic valve disease and effect of distinct overload subsets. Am J Cardiol. 1997;80:475-480.
40. Legget ME, Kuusisto J, Healy NL, et al. Gender differences in left ventricular function at rest and with exercise in asymptomatic aortic stenosis. Am Heart J. 1996;131:94-100.